ARUVX Mutual Fund

ARUVX Mutual Fund

NAV$10.00
See how much of ARUVX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
-
Expense Ratio
1.05%
Dividend Yield (Current)
-
Holdings
46
Inception Date
Aug 31, 2023
Fund Family
ARGA Investment Management, LP
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

Asset Allocation

Stocks: 100.00%
See how much of ARUVX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
ELV:BRElevance Health, Inc.4.56%
BMRNBiomarin Pharmaceutical Inc.4.41%
MHKMohawk Industries Inc.3.93%
TROWT Rowe Price Group Inc3.72%
CRMSalesforce Inc.3.45%
Top 10 Concentration: 35.44%Report Date: Jun 30, 2026
Download all 46 holdings for ARUVX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

ARUVX Mutual Fund Overview

ARUVX Mutual Fund (ARGA Value Fund Investor Class) is managed by ARGA Investment Management, LP. ARUVX expense ratio is 1.05%, holding 46 positions across sectors including Financials, Materials, Information Technology. Inception date: 2023-08-31.

ARUVX performance shows data across multiple time periods..

ARUVX top holdings include Elevance Health, Inc. (4.6%), Biomarin Pharmaceutical Inc. (4.4%), Mohawk Industries Inc. (3.9%), T Rowe Price Group Inc (3.7%), Salesforce Inc. (3.5%). Go to all ARUVX holdings, ARUVX sectors, or ARUVX dividends.

ARUVX can be compared against other funds. Use ARUVX overlap to find shared positions, or ARUVX vs another fund for a side-by-side view. ARUVX alternatives are available via the screener, along with tax-loss harvesting opportunities.